不提升真菌诊断能力则无法实现抗微生物耐药议程
抗微生物耐药主要源于抗菌药物和抗真菌药物过度使用,而真菌疾病缺乏常规诊断检测加剧了经验性用药问题。文章列举4种常见临床情境说明该问题,并主张所有社区都应获得非培养真菌诊断方法,以改善临床结局、抗菌药物管理和耐药控制。
要点
- 真菌疾病缺乏常规诊断检测会加剧抗菌药物和抗真菌药物的经验性过度使用。
- 侵袭性念珠菌病、慢性肺曲霉病、真菌性哮喘和肺孢子菌肺炎是真菌诊断不足的典型情境。
- 非培养真菌诊断方法可改善临床结局并促进抗菌药物管理和耐药控制。
核心结论
- 不改善真菌诊断能力,抗微生物耐药议程无法实现。
主要发现
- 医院和ICU中真菌脓毒症诊断不准确,导致侵袭性念珠菌病患者不恰当使用广谱抗菌药物。
- 涂片阴性肺结核患者中慢性肺曲霉病诊断失败。
- 真菌性哮喘误诊导致不必要使用抗菌药物而非抗真菌药物,并漏诊COPD患者中危及生命的侵袭性曲霉病。
- HIV阳性患者中肺孢子菌肺炎存在过度治疗和治疗不足。
临床怎么用
- 所有社区都应获得非培养真菌诊断方法,以改善临床结局、抗菌药物管理和抗微生物耐药控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial resistance, a major public health concern, largely arises from excess use of antibiotic and antifungal drugs. Lack of routine diagnostic testing for fungal diseases exacerbates the problem of antimicrobial drug empiricism, both antibiotic and antifungal. In support of this contention, we cite 4 common clinical situations that illustrate this problem: 1) inaccurate diagnosis of fungal sepsis in hospitals and intensive care units, resulting in inappropriate use of broad-spectrum antibacterial drugs in patients with invasive candidiasis; 2) failure to diagnose chronic pulmonary aspergillosis in patients with smear-negative pulmonary tuberculosis; 3) misdiagnosis of fungal asthma, resulting in unnecessary treatment with antibacterial drugs instead of antifungal drugs and missed diagnoses of life-threatening invasive aspergillosis in patients with chronic obstructive pulmonary disease; and 4) overtreatment and undertreatment of Pneumocystis pneumonia in HIV-positive patients. All communities should have access to nonculture fungal diagnostics, which can substantially benefit clinical outcome, antimicrobial stewardship, and control of antimicrobial resistance.
引用
- Denning DW, Perlin DS, Muldoon EG, et al. Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities. Emerg Infect Dis. 2017. PMID: 27997332. doi:10.3201/eid2302.152042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。